Reply: Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Nature Publishing Group
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670490/ |